Stock listing
PYC Stock Price, News, Filings & Events — Physiomics Plc
Selected listing: PYC · LSE · GBX · GB
This page tracks Physiomics Plc's PYC:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PYC:LSE. PYC:LSE is the stock-level entry point for investors researching Physiomics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Physiomics Plc is a public company listed on the UK market under the ticker PYC, with a market capitalization of approximately £3.36 million. The company specializes in providing advanced modeling and simulation services to the pharmaceutical and biotechnology sectors. Physiomics aims to enhance drug development processes through its innovative technology solutions.
- Ticker
- PYC:LSE
- Asset type
- Stock
- Market cap
- $3.2M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- LSE
- Currency
- GBX
Physiomics Plc PYC:LSE stock context
This page tracks Physiomics Plc's PYC:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PYC:LSE. PYC:LSE is the stock-level entry point for investors researching Physiomics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Physiomics Plc is a public company listed on the UK market under the ticker PYC, with a market capitalization of approximately £3.36 million. The company specializes in providing advanced modeling and simulation services to the pharmaceutical and biotechnology sectors. Physiomics aims to enhance drug development processes through its innovative technology solutions.
Latest news from Physiomics Plc
Physiomics Plc earnings calls
PHYSIOMICS PLC (PYC) — Investor Update
April 9, 2026 · Replay with transcript and chapters
PHYSIOMICS PLC (PYC) — Audited results for the year ended 30 June 2025,
October 1, 2025 · Replay with transcript and chapters
PHYSIOMICS PLC (PYC) — Interim Results
March 10, 2025 · Replay with transcript and chapters
PHYSIOMICS PLC (PYC) — Full Year Results
October 7, 2024 · Replay with transcript and chapters
PHYSIOMICS PLC (PYC) — Interim Results
March 18, 2024 · Replay with transcript and chapters
PHYSIOMICS PLC (PYC) — Business Update
November 17, 2023 · Replay with transcript and chapters
Research Physiomics Plc
Physiomics Plc investor report
Review AI stock analysis and investor report context for PYC:LSE.
Physiomics Plc company profile
View the public company page for Physiomics Plc on 6ix.
Physiomics Plc news
Read company news and market updates connected to Physiomics Plc.
Physiomics Plc investor events
Find investor webinars, events, and replay context for Physiomics Plc.
Alternate listings
A2DG6B:LSX
DE · EUR
Alternate listing for Physiomics Plc; the primary context on this page is PYC:LSE.
A2DG6B:LS
DE · EUR
Alternate listing for Physiomics Plc; the primary context on this page is PYC:LSE.
RVW1:FWB
DE · EUR
Alternate listing for Physiomics Plc; the primary context on this page is PYC:LSE.
RVW1:SWB
DE · EUR
Alternate listing for Physiomics Plc; the primary context on this page is PYC:LSE.